WO2007047829A3 - Nouvelles protéines hétérodimères et utilisations de celles-ci - Google Patents

Nouvelles protéines hétérodimères et utilisations de celles-ci Download PDF

Info

Publication number
WO2007047829A3
WO2007047829A3 PCT/US2006/040860 US2006040860W WO2007047829A3 WO 2007047829 A3 WO2007047829 A3 WO 2007047829A3 US 2006040860 W US2006040860 W US 2006040860W WO 2007047829 A3 WO2007047829 A3 WO 2007047829A3
Authority
WO
WIPO (PCT)
Prior art keywords
heterodimeric proteins
amino acid
acid sequence
novel heterodimeric
hybrid proteins
Prior art date
Application number
PCT/US2006/040860
Other languages
English (en)
Other versions
WO2007047829A2 (fr
Inventor
Sean D Mckenna
Robert K Campbell
Xuliang Jiang
Luca Giampiero De
Meijia Yang
Original Assignee
Serono Lab
Sean D Mckenna
Robert K Campbell
Xuliang Jiang
Luca Giampiero De
Meijia Yang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab, Sean D Mckenna, Robert K Campbell, Xuliang Jiang, Luca Giampiero De, Meijia Yang filed Critical Serono Lab
Publication of WO2007047829A2 publication Critical patent/WO2007047829A2/fr
Publication of WO2007047829A3 publication Critical patent/WO2007047829A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des protéines hybrides comprenant au moins deux chaînes polypeptidiques, chaque chaîne polypeptidique comprenant une séquence d'acides aminés d'une cytokine ou d'un fragment de celle-ci liée à une séquence d'acides aminés d'une sous-unité d'une hormone protéique hétérodimère. L'invention concerne également des procédés de fabrication et d'utilisation de telles protéines hybrides dans le traitement de différentes maladies.
PCT/US2006/040860 2005-10-19 2006-10-17 Nouvelles protéines hétérodimères et utilisations de celles-ci WO2007047829A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72818405P 2005-10-19 2005-10-19
US60/728,184 2005-10-19

Publications (2)

Publication Number Publication Date
WO2007047829A2 WO2007047829A2 (fr) 2007-04-26
WO2007047829A3 true WO2007047829A3 (fr) 2007-10-04

Family

ID=37963270

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/040860 WO2007047829A2 (fr) 2005-10-19 2006-10-17 Nouvelles protéines hétérodimères et utilisations de celles-ci

Country Status (1)

Country Link
WO (1) WO2007047829A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9493578B2 (en) 2009-09-02 2016-11-15 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007062037A2 (fr) * 2005-11-21 2007-05-31 Laboratoires Serono Sa Compositions et methodes de production de molecules hybrides de fixant a des antigenes, et leurs utilisations
AU2011283694B2 (en) 2010-07-29 2017-04-13 Xencor, Inc. Antibodies with modified isoelectric points
US10851178B2 (en) 2011-10-10 2020-12-01 Xencor, Inc. Heterodimeric human IgG1 polypeptides with isoelectric point modifications
US10968276B2 (en) 2013-03-12 2021-04-06 Xencor, Inc. Optimized anti-CD3 variable regions
US10738132B2 (en) 2013-01-14 2020-08-11 Xencor, Inc. Heterodimeric proteins
US9605084B2 (en) 2013-03-15 2017-03-28 Xencor, Inc. Heterodimeric proteins
US9701759B2 (en) 2013-01-14 2017-07-11 Xencor, Inc. Heterodimeric proteins
US10131710B2 (en) 2013-01-14 2018-11-20 Xencor, Inc. Optimized antibody variable regions
US11053316B2 (en) 2013-01-14 2021-07-06 Xencor, Inc. Optimized antibody variable regions
US10487155B2 (en) 2013-01-14 2019-11-26 Xencor, Inc. Heterodimeric proteins
WO2014113510A1 (fr) 2013-01-15 2014-07-24 Xencor, Inc. Elimination rapide de complexes antigéniques à l'aide de nouveaux anticorps
EP3421495A3 (fr) 2013-03-15 2019-05-15 Xencor, Inc. Modulation de cellules t avec des anticorps bispécifiques et des fusions fc
US10106624B2 (en) 2013-03-15 2018-10-23 Xencor, Inc. Heterodimeric proteins
US10858417B2 (en) 2013-03-15 2020-12-08 Xencor, Inc. Heterodimeric proteins
US10519242B2 (en) 2013-03-15 2019-12-31 Xencor, Inc. Targeting regulatory T cells with heterodimeric proteins
BR112016022385A2 (pt) 2014-03-28 2018-06-19 Xencor, Inc anticorpos específicos que se ligam a cd38 e cd3
AU2015353416C1 (en) 2014-11-26 2022-01-27 Xencor, Inc. Heterodimeric antibodies that bind CD3 and CD38
CN110894240B (zh) 2014-11-26 2022-04-15 森科股份有限公司 结合cd3和肿瘤抗原的异二聚体抗体
US10259887B2 (en) 2014-11-26 2019-04-16 Xencor, Inc. Heterodimeric antibodies that bind CD3 and tumor antigens
IL290459B2 (en) 2014-12-05 2023-11-01 Hope City Modified T cells - CS1-targeted chimeric antigen receptor
WO2016105450A2 (fr) 2014-12-22 2016-06-30 Xencor, Inc. Anticorps trispécifiques
WO2016141387A1 (fr) 2015-03-05 2016-09-09 Xencor, Inc. Modulation de lymphocytes t avec des anticorps bispécifiques et des hybrides fc
JP7058219B2 (ja) 2015-12-07 2022-04-21 ゼンコア インコーポレイテッド Ｃｄ３及びｐｓｍａに結合するヘテロ二量体抗体
CA3026151A1 (fr) 2016-06-14 2017-12-21 Xencor, Inc. Anticorps inhibiteurs de points de controle bispecifiques
EP3475304B1 (fr) 2016-06-28 2022-03-23 Xencor, Inc. Anticorps hétérodimériques qui se lient au récepteur 2 de la somatostatine
US10793632B2 (en) 2016-08-30 2020-10-06 Xencor, Inc. Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
PE20191034A1 (es) 2016-10-14 2019-08-05 Xencor Inc Proteinas de fusion heterodimericas biespecificas que contienen proteinas de fusion fc il-15/il-15r y fragmentos de anticuerpo pd-1
AU2018291497A1 (en) 2017-06-30 2020-01-16 Xencor, Inc. Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15Ra and antigen binding domains
US10981992B2 (en) 2017-11-08 2021-04-20 Xencor, Inc. Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
EP3706793A1 (fr) 2017-11-08 2020-09-16 Xencor, Inc. Anticorps bispécifiques et monospécifiques utilisant de nouvelles séquences anti-pd-1
JP2021506291A (ja) 2017-12-19 2021-02-22 ゼンコア インコーポレイテッド 改変されたｉｌ−２ ｆｃ融合タンパク質
CA3096052A1 (fr) 2018-04-04 2019-10-10 Xencor, Inc. Anticorps heterodimeres qui se lient a la proteine d'activation des fibroblastes
CA3097741A1 (fr) 2018-04-18 2019-10-24 Xencor, Inc. Proteines de fusion heterodimeres ciblant tim-3 contenant des proteines de fusion fc d'il-15/il-15ra et domaines de liaison a l'antigene de tim-3
US11524991B2 (en) 2018-04-18 2022-12-13 Xencor, Inc. PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof
SG11202103192RA (en) 2018-10-03 2021-04-29 Xencor Inc Il-12 heterodimeric fc-fusion proteins
JP2022523946A (ja) 2019-03-01 2022-04-27 ゼンコア インコーポレイテッド Ｅｎｐｐ３およびｃｄ３に結合するヘテロ二量体抗体
WO2021231976A1 (fr) 2020-05-14 2021-11-18 Xencor, Inc. Anticorps hétérodimères qui se lient à l'antigène membranaire spécifique de la prostate (psma) et cd3
JP2023538891A (ja) 2020-08-19 2023-09-12 ゼンコア インコーポレイテッド 抗ｃｄ２８組成物
CA3200011A1 (fr) * 2020-10-28 2022-05-05 Centre National De La Recherche Scientifique (Cnrs) Nouvelle isoforme de variant d'epissage du vegf
AU2022232375A1 (en) 2021-03-09 2023-09-21 Xencor, Inc. Heterodimeric antibodies that bind cd3 and cldn6
KR20230154311A (ko) 2021-03-10 2023-11-07 젠코어 인코포레이티드 Cd3 및 gpc3에 결합하는 이종이량체 항체

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194177B1 (en) * 1996-02-20 2001-02-27 Applied Research Systems Ars Holding N.V. DNA encoding a hybrid heterodimeric protein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194177B1 (en) * 1996-02-20 2001-02-27 Applied Research Systems Ars Holding N.V. DNA encoding a hybrid heterodimeric protein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEN ET AL.: "The Carboxy-Terminal Region of the Glycoprotein Hormone Alpha-Subunit: Contribution to Receptor Binding and Signaling in Human Chorionic Gonadotropin", MOL. ENDOC., vol. 6, no. 6, 1992, pages 914 - 919, XP002445836 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9493578B2 (en) 2009-09-02 2016-11-15 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens

Also Published As

Publication number Publication date
WO2007047829A2 (fr) 2007-04-26

Similar Documents

Publication Publication Date Title
WO2007047829A3 (fr) Nouvelles protéines hétérodimères et utilisations de celles-ci
WO2007062037A3 (fr) Compositions et methodes de production de molecules hybrides de fixant a des antigenes, et leurs utilisations
EP2322552A3 (fr) Anticorps se liant à IL-1 beta et fragments de ceux-ci
WO2005021592A3 (fr) Augmentation de la demi-vie circulante de proteines de type interleukine 2
WO2004092215A3 (fr) Methodes therapeutiques utilisant des agents liants specifiques de l'angiopoietine-2 humaine
ATE529442T1 (de) Verbesserte humane interferon-moleküle und ihre verwendungen
WO2004094613A3 (fr) Complexe proteinique polyvalent
PL1626985T3 (pl) Generowanie sztucznych białek wiążących na bazie białek ubikwitynowych
BRPI0514115A (pt) terapia de combinação empregando-se proteìnas de fusão de transferrina compreendendo glp-1
WO2006033859A3 (fr) Production de proteines: compositions et methodes
EA200700136A1 (ru) Анти-cd154-антитела
WO2009147248A3 (fr) Séquences d'acides aminés dirigées contre des protéines d'enveloppe d'un virus, et polypeptides comprenant ces séquences destinés au traitement de maladies virales
GEP20105111B (en) Rage fusion proteins and methods of use
NZ562436A (en) Toll-like receptor 14 (TLR14) and use thereof
WO2009095489A3 (fr) Séquences d'acides aminés améliorées dirigées contre il-6r et polypeptides les comprenant pour le traitement de maladies et troubles associés à une signalisation facilitée par il-6
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
TW200722436A (en) A peptide-immunoglobulin-conjugate
WO2005056585A3 (fr) Protéines s du coronavirus du sars et leurs utilisations
WO2007087053A3 (fr) Compositions à base de variantes de bmp-7, procédés et utilisations
WO2006075253A3 (fr) Peptides destines a desensibiliser des sujets allergiques au poil de chien ou aux squames, et compositions contenant ces peptides
WO2005059131A3 (fr) Proteine fixant des proteines en miniature et leurs applications
WO2005051975A3 (fr) Procedes d'obtention de molecules presentant une immunogenicite reduite
WO2009083968A8 (fr) Nouvelle protéine
WO2008010096A3 (fr) Procédé de préparation de polypeptides mycobactériens recombinés de levure et leur utilisation pour diagnostiquer des maladies associées à des mycobactéries
WO2001053339A3 (fr) Proteines de surface specifiques de l'oeuf

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06826263

Country of ref document: EP

Kind code of ref document: A2